- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Proposed standard for CAC CT screening reduces dose and improves diagnosis
A new standard proposed by a consortium of researchers and manufacturers at the RSNA meeting would make coronary artery calcium (CAC) screening with CT safer and more useful in assessing early heart disease.
A new standard proposed by a consortium of researchers and manufacturers at the RSNA meeting would make coronary artery calcium (CAC) screening with CT safer and more useful in assessing early heart disease.
The proposed standards would ensure that all manufacturers play by the same rules, said Cynthia McCollough, Ph.D., an associate professor of radiologic physics at the Mayo Clinic in Rochester, MN.
"The problem has been in the variability of the scoring in CAC screening," she said. "There are a variety of CT scanners using different scoring systems to produce CAC screening results. In order for these numbers to be meaningful and comparable, we need to be measuring and scoring in the same way."
The consortium developed a calcium calibration phantom for testing CAC screening on all major manufacturers' CT scanners. In addition, the group set standards for body size that will help reduce the radiation dose to small and medium-sized patients.
The new standard uses a physically based score to evaluate calcification, which will allow portability of screening between machines. Instead of using a CT number, it measures the actual density of calcium in the artery. Any amount greater than 100 mg/cc is considered significant.
McCollough cautioned that the new standard has some drawbacks; for example, it becomes less accurate as more motion is introduced into the study.
The consortium included researchers from the Mayo Clinic, the Cleveland Clinic, and the Institute for Medical Physics in Erlangen, Germany, as well as participants from the medical divisions of GE, Philips, Siemens, and Toshiba.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
